Moxifloxacin Ab (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Ab, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It is indicated for the treatment of several serious bacterial infections in adult patients, including community‑acquired pneumonia, acute bacterial sinusitis and complicated intra‑abdominal infections.

GNH USA supplies Moxifloxacin Ab as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under EU quality standards. The company maintains rigorous quality control and supports global distribution networks for reliable access.

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections in the respiratory, skin and intra‑abdominal systems. - Community‑acquired bacterial pneumonia: achieves bacterial eradication and clinical cure in adult patients. - Acute bacterial sinusitis: reduces symptoms and eliminates the causative pathogens. - Acute bacterial exacerbation of chronic bronchitis: improves lung function and shortens disease duration. - Skin and skin‑structure infections: provides effective antimicrobial coverage for Gram‑negative and Gram‑positive organisms. - Complicated intra‑abdominal infections: facilitates resolution of infection when combined with appropriate surgical management.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertigo or light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles. - QT interval prolongation: may lead to cardiac arrhythmias. - Severe hypersensitivity reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Moxifloxacin, clinicians should consider several safety precautions to minimize risks. - Pregnancy: Category C; use only if potential benefits justify potential fetal risk. - Elderly patients: monitor for tendon disorders and CNS effects. - Renal impairment: dose adjustment may be required based on renal function. - History of QT prolongation: avoid or use with ECG monitoring. - Concomitant use with corticosteroids: increase risk of tendon rupture; assess benefits. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Moxifloxacin interacts with several drug classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Theophylline: increased serum levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use raises tendon rupture risk. - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia. - Cyclosporine: may increase moxifloxacin plasma concentrations.